Abstract
720MO IBI354 (anti-HER2 antibody-drug conjugate [ADC]) in patients (pts) with advanced gynecological cancers (Gynecol C): Results from a phase I study
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have